1-20 of 26
Sort by
News

A Cure for Congress?

Published: 2021
View News
News

Long-Term Study Confirms Durable Responses With Reduced-Intensity Conditioning AlloHCT in High-Risk CLL

Published: 2021
View News
News

Musing on Medical Marvels

Published: 2021
View News
News

Ned Sharpless Named New NCI Director, 2017 Pew-Stewart Cancer Research Scholars Announced, and more

Published: 2021
View News
News

For Lenalidomide-Refractory Myeloma, Pomalidomide Is a Safe, Effective Secondline Option

Published: 2021
View News
News

How would you treat a patient with aplastic anemia who refuses transfusions for religious reasons? (Reader's Responce)

Published: 2021
View News
News

Randomized Study of Darbepoetin Alfa Shows Modest Reduction in RBC Transfusions in Patients With MDS and Anemia

Published: 2021
View News
News

High-Dose Chemotherapy Plus Transplantation Improves PFS, But Not OS, in Myeloma Patients

Published: 2021
View News
News

NIH Will Not Cap Funding to Individual Laboratories

Published: 2021
View News
News

Pembrolizumab Trials Halt Enrollment After Patient Deaths

Published: 2021
View News
News

All Clinical Trials of Vadastuximab Talirine Suspended Following Patient Deaths

Published: 2021
View News
News

FDA Approves Rituximab and Hyaluronidase Combination for Several Lymphomas

Published: 2021
View News
News

FDA Approves Betrixaban for Venous Thromboembolism

Published: 2021
View News
News

ASH Selects Outstanding Trainees for Award Programs, Honorific Award Winners, and more

Published: 2021
View News
News

Managing Toxicities of Dasatinib in Patients With CP-CML

Published: 2021
View News
News

Hemophilia: Understanding Inhibitors

Published: 2021
View News
News

Is Anticoagulant Therapy to Prevent Recurrent VTE Worth the Bleeding Risk in Older Patients With Cancer?

Published: 2021
View News
News

Phase II Results Show Activity of Polatuzumab Vedotin Combination in DLBCL

Published: 2021
View News
News

Evaluating HCT Outcomes in Patients With Beta-Thalassemia

Published: 2021
View News
News

Fourth Drug’s the Charm? Comparing Combination Therapies in the Myeloma XI Trial

Published: 2021
View News